Volume 53, Issue 3 pp. 979-981
Full Access

In Vivo Modulation of the N-Methyl-D-Aspartate Receptor Complex by D-Serine: Potentiation of Ongoing Neuronal Activity as Evidenced by Increased Cerebellar Cyclic GMP

Paul L. Wood

Corresponding Author

Paul L. Wood

CNS Diseases Research, G. D. Searle and Company. St. Louis, Missouri, U.S.A.

Address correspondence and reprint requests to Dr. P. L. Wood at CNS Diseases Research, G. D. Searle and Co., 700 Chesterfield Village Parkway, St. Louis, MO 63198, U.S.A.Search for more papers by this author
Mark R. Emmett

Mark R. Emmett

CNS Diseases Research, G. D. Searle and Company. St. Louis, Missouri, U.S.A.

Search for more papers by this author
Tadimeti S. Rao

Tadimeti S. Rao

CNS Diseases Research, G. D. Searle and Company. St. Louis, Missouri, U.S.A.

Search for more papers by this author
Steve Mick

Steve Mick

CNS Diseases Research, G. D. Searle and Company. St. Louis, Missouri, U.S.A.

Search for more papers by this author
Julie Cler

Julie Cler

CNS Diseases Research, G. D. Searle and Company. St. Louis, Missouri, U.S.A.

Search for more papers by this author
Smriti Iyengar

Smriti Iyengar

CNS Diseases Research, G. D. Searle and Company. St. Louis, Missouri, U.S.A.

Search for more papers by this author
First published: September 1989
Citations: 86

Abstract

Direct intracerebellar injections of TV-methyl-D-aspartate (NMDA) or D-serine elicited dose-dependent increases in cerebellar cyclic GMP levels, in vivo in the mouse. The actions of D-serine were antagonized by the competitive NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl) propyl-1-phosphonic acid and by the phen-cyclidine receptor agonist MK-801, observations supporting actions at the NMDA-coupled glycine receptor. In addition, the actions of D-serine were antagonized by a partial agonist (D-cycloserine) and an antagonist (HA-966) of the NMDA-coupled glycine receptor. These data are all consistent with D-serine acting at the NMDA-coupled glycine receptor and represent the first demonstration of glycine receptor potentiation of ongoing NMDA-mediated neuronal activity in the CNS, rather than potentiation of exogenous NMDA.

Abbreviations used:

  • cGMP
  • cyclic GMP
  • CPP
  • 3-(2-carboxypiper-azin-4-yl)propyl-l-phosphonic acid
  • HA-966
  • l-hydroxy-3-amino-pyrrolidone-2
  • NMDA
  • N-methyl-D-aspartate
  • PCP
  • phencyclidine
    • The full text of this article hosted at iucr.org is unavailable due to technical difficulties.